Noninvasive Optoacoustic Imaging of Oxygen Saturation Reveals Hypoxic Hematopoietic Bone Marrow during Systemic Inflammation
Source abstract
Abstract
Inflammation drives various diseases, including cardiovascular, neurodegenerative, and oncological disorders, by altering immune cell dynamics in hematopoietic niches. The bone marrow is the primary site for hematopoietic stem and progenitor cell activity. Here, we present a novel, noninvasive approach using multispectral optoacoustic tomography (MSOT) to track oxygenation dynamics in the murine calvarial bone marrow during acute systemic inflammation induced by lipopolysaccharide (LPS). Our MSOT system provided real-time, label-free imaging of hemoglobin oxygen saturation (sO 2 ), revealing significant reductions in sO 2 levels in lipopolysaccharide-treated mice, indicative of increased oxygen consumption. Co-registration with microCT enabled precise vascular mapping. Hypoxia was confirmed by ex vivo Pimonidazole staining and optical imaging and was associated with elevated neutrophil counts and enhanced hematopoietic activation. These findings demonstrate MSOT’s potential for noninvasive imaging of marrow oxygenation, offering insights into inflammation-driven hematopoietic activation and supporting the development of therapies targeting oxygen-sensitive pathways.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Thermal Regulation in Medicine · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Faculty of Biomedical Engineering
Technion−Israel Institute of Technology
NYU Langone Health
Tech4Health and Neuroscience Institutes, and Department of Ophthalmology
Faculty of Medicine
University of Zurich
Department of Information Technology and Electrical Engineering
ETH Zurich
Faculty of Electrical Engineering
Funding
Israel Science Foundation · BIRAX · Zeff Fellowship · Technion Human Health Initiative · Teva BioInnovator Grant
References (38)
Show source-provided references
1. 10.1038/s41591-019-0675-010.1038/s41591-019-0675-0 ↗
2. 10.1152/physiol.00025.200510.1152/physiol.00025.2005 ↗
3. 10.1007/s00018-005-5469-510.1007/s00018-005-5469-5 ↗
4. 10.1182/bloodadvances.202100608810.1182/bloodadvances.2021006088 ↗
5. 10.1016/j.immuni.2006.04.00810.1016/j.immuni.2006.04.008 ↗
6. 10.1161/CIRCRESAHA.118.31330210.1161/CIRCRESAHA.118.313302 ↗
7. 10.1038/s44161-021-00002-810.1038/s44161-021-00002-8 ↗
8. 10.1182/blood.V124.21.2396.239610.1182/blood.V124.21.2396.2396 ↗
9. 10.1038/nature1303410.1038/nature13034 ↗
10. 10.1002/anie.20141064610.1002/anie.201410646 ↗
11. 10.3390/cancers1513333610.3390/cancers15133336 ↗
12. 10.1097/RLU.000000000000028610.1097/RLU.0000000000000286 ↗
13. 10.1259/bjr.2018064210.1259/bjr.20180642 ↗
14. 10.1002/mrm.191006031210.1002/mrm.1910060312 ↗
15. 10.1016/j.pacs.2017.06.00410.1016/j.pacs.2017.06.004 ↗
16. 10.1016/j.pacs.2019.01.00310.1016/j.pacs.2019.01.003 ↗
17. 10.1016/j.pacs.2023.10053210.1016/j.pacs.2023.100532 ↗
18. 10.1063/1.219502410.1063/1.2195024 ↗
19. 10.1038/nbt83910.1038/nbt839 ↗
20. 10.1016/B978-0-12-804280-9.00003-210.1016/B978-0-12-804280-9.00003-2 ↗
21. 10.3389/fcell.2021.65357910.3389/fcell.2021.653579 ↗
22. 10.1038/s41551-022-00906-110.1038/s41551-022-00906-1 ↗
23. 10.1016/j.crmeth.2021.10015110.1016/j.crmeth.2021.100151 ↗
24. 10.1038/nprot.2010.16810.1038/nprot.2010.168 ↗
25. 10.1038/s41586-020-1971-z10.1038/s41586-020-1971-z ↗
26. 10.1038/s41467-023-39069-110.1038/s41467-023-39069-1 ↗
27. 10.1002/jbmr.453310.1002/jbmr.4533 ↗
28. 10.1152/ajpcell.00044.201110.1152/ajpcell.00044.2011 ↗
29. 10.4049/jimmunol.110325310.4049/jimmunol.1103253 ↗
30. 10.1016/j.stem.2017.06.01310.1016/j.stem.2017.06.013 ↗
31. 10.1128/IAI.71.8.4414-4420.200310.1128/IAI.71.8.4414-4420.2003 ↗
32. 10.1038/s41593-018-0213-210.1038/s41593-018-0213-2 ↗
33. 10.1101/2022.10.26.51383010.1101/2022.10.26.513830 ↗
34. 10.1007/s10877-012-9348-y10.1007/s10877-012-9348-y ↗
35. 10.1016/j.pacs.2020.10018110.1016/j.pacs.2020.100181 ↗
36. 10.1038/s41598-017-07683-x10.1038/s41598-017-07683-x ↗
37. 10.1038/s41377-024-01644-610.1038/s41377-024-01644-6 ↗
38. 10.1016/j.pacs.2023.10056910.1016/j.pacs.2023.100569 ↗